The Congressionally Directed Medical Research Program (CDMRP)
A Peer Reviewed Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) for Fiscal Year 2021 (FY21) is included in the United States FY21 Department of Defense appropriation at $175 Million (M). The FY21 TBIPHRP will be managed by The Congressionally Directed Medical Research Program (CDMRP) according to Congressional intent to support research in the treatment, prevention, and detection of Traumatic Brain Injury and improved psychological health. Responses to the Request for Information (RFI) will support market research in the identification of knowledge gaps, outcomes, and product needs in traumatic brain injury and psychological health research and be used for planning of the FY21 TBIPHRP.
The CDMRP will utilize its two-tiered review process to efficiently manage the TBIPHRP. The CDMRP will also hold a TBIPHRP Stakeholders meeting where experts from different subject areas are brought together to identify knowledge gaps, outcomes, and product needs for the state of the science and patient care. After the stakeholders meeting, a vision setting meeting will be held to recommend an investment strategy to answer some of the unmet medical needs, knowledge gaps, and consumer concerns.
For more information, please visit the TBIPHRP website.
Request for Information is due by March 5, 2021.
Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.